Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

HHLR Advisors, Ltd.

At a glance: HHLR Advisors, Ltd. is 10% Owner at ArriVent BioPharma (AVBP). Their latest SEC Form 4, filed Feb 3, 2026, reported a sale of $13.0M. On file: 0 purchase lines ($0) and 1 sale line ($13.0M).

Disclosed holdings: about $42.1M of AVBP stock: 3,929,117 shares (including shares held indirectly, e.g. through a trust or fund) reported on its latest Form 4 (filed Feb 3, 2026), valued at the Nov 20, 2026 close of $10.71. This counts only AVBP shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

10% Owner at ArriVent BioPharma, Inc. (AVBP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13.0M

HHLR Advisors, Ltd.'s InsiderPrint

2 trades from SEC Form 4 filings, 2024 to 2025, drawn as one fingerprint.

InsiderPrint of HHLR Advisors, Ltd.: 2 trades, 2024 to 20252024: 1 buy, 0 sales2025: 0 buys, 1 sale
  • Bump outward: a purchase (1)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 3SEC AVBPArriVent BioPharma, Inc. Sell 555,5553,929,117 held (−12%) $23.37 $13.0M -54.2%

Follow HHLR Advisors, Ltd.

Get one email when HHLR Advisors, Ltd. files a new purchase or sale. Free.

At most one email a day about HHLR Advisors, Ltd., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.